While cases with BRAF TCGA driver mutations alone were consistent with previously reported data suggesting a predominance of class I mutations in BRAF mutant melanoma, only one of eleven BRAF co-mutated cases (co-occurring with either NRAS or NF1) exhibited a class I BRAF mutation. This evidence concerns the gene NRAS and melanoma.